Healthcare Triangle (NASDAQ:HCTI) & OptimizeRx (NASDAQ:OPRX) Head-To-Head Review

Healthcare Triangle (NASDAQ:HCTI) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Valuation & Earnings

This table compares Healthcare Triangle and OptimizeRx”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Healthcare Triangle	$13.89 million	0.23	-$9.48 million	($670.40)	-0.01
OptimizeRx	$109.43 million	1.26	$5.13 million	$0.23	31.91

OptimizeRx has higher revenue and earnings than Healthcare Triangle. Healthcare Triangle is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and price targets for Healthcare Triangle and OptimizeRx, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Healthcare Triangle	1	0	0	0	1.00
OptimizeRx	1	2	6	0	2.56

OptimizeRx has a consensus target price of $11.21, indicating a potential upside of 52.78%. Given OptimizeRx’s stronger consensus rating and higher possible upside, analysts clearly believe OptimizeRx is more favorable than Healthcare Triangle.

Profitability

This table compares Healthcare Triangle and OptimizeRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Healthcare Triangle	-66.85%	-125.45%	-36.06%
OptimizeRx	5.33%	9.58%	7.47%

Volatility & Risk

Healthcare Triangle has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500.

Insider & Institutional Ownership

0.3% of Healthcare Triangle shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 0.1% of Healthcare Triangle shares are owned by company insiders. Comparatively, 7.5% of OptimizeRx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

OptimizeRx beats Healthcare Triangle on 14 of the 14 factors compared between the two stocks.

About Healthcare Triangle

Healthcare Triangle, Inc. (NASDAQ:HCTI) provides information technology and digital transformation services for the healthcare and life sciences industries. The company helps organizations modernize their technology environments, manage data, and support secure, compliant operations. Its offerings include cloud services, data and analytics solutions, interoperability and application modernization, cybersecurity, managed services, and professional consulting. Healthcare Triangle also develops technology solutions intended to support electronic health record environments, clinical and business workflows, and the use of artificial intelligence and other advanced analytics in healthcare.

About OptimizeRx

OptimizeRx is a healthcare technology company that connects life sciences companies with healthcare professionals and patients through digital communications. Its platform uses channels such as electronic health records and other clinical workflows to deliver relevant information at the point of care. The company’s services support programs for medication access and affordability, patient education and engagement, and communication between healthcare providers and life sciences organizations. OptimizeRx also provides tools intended to help life sciences companies reach clinicians and patients through digital channels.